CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
A Phase II Study to Evaluate the Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients Receiving Dose-Dense Doxorubicin/Cyclophosphamide
Gun Min Kim, Joo Hoon Kim, Ji Heung Kim, Young Up Cho, Seung Il Kim, Seho Park, Hyung Seok Park, Ji Ye Kim, Joohyuk Sohn
Cancer Research and Treatment. 2019;51(2):812-818.   Published online 2018 September 19    DOI: https://doi.org/10.4143/crt.2018.383

Excel Download

A Phase II Study to Evaluate the Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients Receiving Dose-Dense Doxorubicin/Cyclophosphamide
Cancer Research and Treatment. 2019;51(2):812-818   Crossref logo
Link1 Link2 Link3

Toxicity of Dose-Dense Docetaxel Followed by Doxorubicin with Cyclophosphamide as Adjuvant Therapy for Breast Cancer in a Phase II Study
Clinical Breast Cancer. 2007;7(9):697-704   Crossref logo
Link1 Link2

Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel (Dose Dense AC Followed by T) Regimen for Breast Cancer
Hospital Pharmacy. 2005;40(4):310-314   Crossref logo
Link1 Link2

Randomized Phase II Adjuvant Trial of Dose-Dense Docetaxel Before or After Doxorubicin Plus Cyclophosphamide in Axillary Node-Positive Breast Cancer
Breast Diseases: A Year Book Quarterly. 2009;20(2):198-199   Crossref logo
Link1 Link2

Pegfilgrastim and darbepoetin alfa as haematopoietic support for adjuvant dose dense doxorubicin + cyclophosphamide-paclitaxel in early stage breast cancer patients – results from the ACCELERATE study
European Journal of Cancer Supplements. 2008;6(7):128   Crossref logo
Link1 Link2

Randomized phase II trial of high-dose 4′-epi-doxorubicin + cyclophosphamide versus high-dose 4′-epi-doxorubicin + cisplatin in previously untreated patients with extensive small cell lung cancer
Lung Cancer. 1993;10(1-2):147   Crossref logo
Link1 Link2

A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09
Supportive Care in Cancer. 2015;24(4):1709-1717   Crossref logo
Link1 Link2 Link3

A Phase II Feasibility Trial of Dose-Dense Docetaxel Followed by Doxorubicin/Cyclophosphamide as Adjuvant or Neoadjuvant Treatment for Women with Node-Positive or High-Risk Node-Negative Breast Cancer
Clinical Breast Cancer. 2008;8(3):242-248   Crossref logo
Link1 Link2

1876 A phase II study of metronomic oral chemotherapy for metastatic breast cancer patients: Safety and efficacy results of vinorelbine, cyclophosphamide plus capecitabine (VEX) combination
European Journal of Cancer. 2015;51:S291-S292   Crossref logo
Link1 Link2

Recurrent metastatic breast cancer treated with high dose cyclophosphamide (CTX) as 2nd line treatment in a phase II study
European Journal of Cancer. 1993;29:S80   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.